Showing results (241-250 of 257) with videos related to
Sort By:
Pageof 26
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|July 18, 2009
Pseudoangiomatous stromal hyperplasia of the breast in pediatric patients: an underrecognized entityBahig M Shehata, Inessa Fishman, Margaret H Collings, et al.Bone Marrow Transplantation|December 12, 2002
Optimising parameters for peripheral blood leukapheresis after r-metHuG-CSF (filgrastim) and r-metHuSCF (ancestim) in patients with multiple myeloma: a temporal analysis of CD34(+) absolute counts and subsetsI H Chin-Yee, M Keeney, A K Stewart, et al.Bone Marrow Transplantation|June 29, 2010
Pericardial effusion post-SCT in pediatric recipients with signs and/or symptoms of cardiac diseaseM Neier, Z Jin, C Kleinman, et al.Leukemia|June 19, 2014
Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphomaP Satwani, Z Jin, P L Martin, et al.Journal of Pediatric Surgery|August 7, 2019
Multicenter retrospective comparison of spontaneous intestinal perforation outcomes between primary peritoneal drain and primary laparotomySamantha Ahle, Faidah Badru, Rachelle Damle, et al.Bone Marrow Transplantation|September 7, 2010
A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescentsJ Styczynski, B Tallamy, I Waxman, et al.Transplantation and Cellular Therapy|April 30, 2025
A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children's Oncology Group (ACCL1633)E J Ladas, W Collier, H Park, et al.Bone Marrow Transplantation|May 7, 2014
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell diseaseM Bhatia, Z Jin, C Baker, et al.Journal of Pediatric Surgery|October 4, 2018
Adherence to APSA activity restriction guidelines and 60-day clinical outcomes for pediatric blunt liver and splenic injuries (BLSI)David M Notrica, Lois W Sayrs, Nidhi Krishna, et al.Cancer|December 19, 2025
Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) studyIrfan Yasin, Anna Stengel, Haipeng Shao, et al.Pageof 26